To address the biological significance of CEBPG, we selected three AML cell lines with high CEBPG protein levels shown in Fig. 1d (THP-1, NB4 and MV4-11) and performed shRNA-mediated knockdown of CEBPG using three independent shRNAs (Table 1). The gene discussed is CEBPG; the disease is acute myeloid leukemia.